Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX
· Real-Time Price · USD
0.80
0.06 (8.65%)
At close: Aug 15, 2025, 12:39 PM
Context Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.83M | -4.58M | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M | -5.87M | -5.01M | -6.31M | -3.56M | -3.85M | -3.99M | -3.44M | -3.09M | -1.44M | -5.03M | -892.05K |
Depreciation & Amortization | 4.07K | 4.05K | 2.93K | 2.81K | 2.57K | 2.57K | 2.57K | 3.09K | 3.19K | 3.19K | 3.19K | 3.19K | 2.88K | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 389.11K | 293.72K | 231.82K | 213K | 157.04K | 240.01K | 256.05K | 254.95K | 283.1K | 282.76K | 243.64K | 276.52K | 241.32K | 214.96K | 204.38K | 161.82K | 119.36K | 25.51K |
Other Working Capital | n/a | -339.27K | -2.23M | 82.46K | 217.63K | -597.75K | -1.27M | 1.51M | 90.95K | -2.1K | -82.84K | -490.53K | 425.28K | 658.47K | -1.37M | -764.88K | 378.47K | 396.72K |
Other Non-Cash Items | 12.69M | 26.01K | 25.32K | 14.77M | n/a | n/a | -294.02K | 7.52K | 22.37K | 22.07K | 21.79K | 21.5K | 521.22K | 14.02K | -18.24K | -124.32K | 3.46M | 53.67K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 294.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 774.9K | -774.9K | -1.82M | 544.25K | -1.26M | -935.4K | -715.9K | 2.15M | 71.55K | 271.83K | -641.51K | 559K | 415.91K | -610.92K | -2.06M | 1.36M | -628.15K | -902.38K |
Operating Cash Flow | 5.03M | -5.03M | -4.91M | -1.93M | -3.36M | -4.36M | -7.23M | -3.46M | -4.63M | -5.73M | -3.93M | -2.99M | -2.81M | -3.82M | -4.96M | -43.63K | -2.08M | -1.72M |
Capital Expenditures | n/a | -33.95K | n/a | -7.32K | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -1.84K | -35K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -14.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | n/a | n/a | -250K | n/a | -250K | n/a |
Investing Cash Flow | n/a | -33.95K | n/a | -14.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -1.84K | -35K | -250K | n/a | -250K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -15.27K | n/a | n/a | 94.8M | n/a | n/a | n/a | n/a | n/a | n/a | -102.07K | n/a | -102.07K | 54.23M | -816.92K | n/a | n/a |
Financial Cash Flow | n/a | -15.27K | 14.54M | -44.63K | 94.8M | n/a | n/a | n/a | n/a | n/a | n/a | -102.07K | n/a | -102.07K | 54.23M | -816.92K | 1.95M | 3.03M |
Net Cash Flow | -5.84M | -5.08M | 9.63M | -16.74M | 91.45M | -4.36M | -7.23M | -3.46M | -4.63M | -5.73M | -3.93M | -3.49M | -2.81M | -3.96M | 49.27M | -860.55K | -380.61K | 1.32M |
Free Cash Flow | 5.03M | -5.06M | -4.91M | -16.69M | -3.36M | -4.36M | -7.23M | -3.46M | -4.63M | -5.73M | -3.93M | -3.49M | -2.81M | -3.86M | -4.96M | -43.63K | -2.08M | -1.72M |